SUMMARY One hundred and nine sick preterm infants were studied, and the data obtained show that hyperphenylalaninaemia is an extremely rare occurrence as long as an adequate source of energy is provided. High concentrations of the other aromatic amino acid (tyrosine) on the other hand, were often encountered and seem to be due to immaturity of an isolated hepatic enzyme as there was no correlation between phenylalanine and tyrosine concentrations. Possible adverse consequences of hypertyrosinaemia are discussed in relation to toxicity and the assessment of hepatic function. We provide reference centiles for plasma amino acid concentrations in this population.
Medical opinion concerning the exact indications for parenteral nutrition in the newborn is far from uniform and its formation is hampered by the lack of prospective randomised trials comparing parenteral with enteral feeding.Y-5 Nevertheless it has been shown that a satisfactory rate of weight gain can be achieved with parenteral nutrition,5 and it continues to be used regularly in the care of ill newborn babies, especially during intensive care of the very low birthweight baby, and after surgery. Many complications of parenteral nutrition have been documented, some relating to the procedure (such as infection of the infusion line), others concerning the requirements and tolerance ofnutrients. Recently concern has been expressed about the amino acid content of one of the most commonly used amino acid solutions, Vamin 9 glucose (KabiVitrum). A series of letters to the Lancet69 reported plasma concentrations of phenylalanine in some parenterally fed newborn babies that were well above the upper limit of 600 ,umol/l recommended in the management of phenylketonuria. 10 These reports are clearly important in alerting users of Vamin 9 glucose to the possibility of achieving potentially toxic phenylalanine concentrations, and hence of the desirability of monitoring plasma concentrations, but they may not be sufficient justification for changing to other amino acid mixtures in search of lower phenylalanine intakes. Each of the competing products on the market has a unique amino acid profile, and it is quite possible that in removing one apparent problem another might be substituted. Also, of the few controlled trials of parenteral nutrition that have been made, most have used Vamin 9 glucose and so there is relatively less information on the clinical effectiveness of other amino acid solutions in the low birthweight baby.
This study was carried out partly to try to confirm our impression that we had not observed the high plasma phenylalanine concentrations being reported from other centres, and partly to generate reference data for plasma amino acid concentrations in a group of parenterally fed very low birthweight babies. We believed that there was every reason to do the latter because there is relatively little reference data on such babies that has been obtained by quantitative analysis.
Patients and methods
The data were obtained from 109 very low birthweight babies receiving parenteral nutrition as part of intensive care for the problems of prematurity. The mean birth weight was 1277 g (range 488-1454) and the mean gestational age was 29 weeks (range 23-42). Parenteral nutrition was started on the second or third day of life with 0-5 g/kg/day of Intralipid 20% (KabiVitrum), 0-5 g/kg/day of Vamin 9 glucose and 10% dextrose, plus minerals, electrolytes, and vitamins. In the absence of contraindications (such as severe jaundice or sepsis) fat and amino acid intakes were increased daily by 0-5 glkg/day, to a maximum of 3-0 g/kg/day of amino acid, and 4-0 g/kg/day of fat. Both fat and amino acids were infused continuously throughout each 24 hours. The plasma was screened daily for lipaemia. The plasma triglyceride concentration was monitored weekly on blood taken during the course of the lipid infusion. The concentration was always below 2-0 mmol/l, and usually below 1.5 mmolIl. The intake of 10% dextrose was gradually increased according to the estimated fluid requirements and carbohydrate tolerance, usually up to a maximum of 180 ml/kg/day. At the maximum, the energy intake was about 0-502 MJ/kg/day; an energy:amino acid ratio of 0-167 MJ/g. Plasma amino acid profiles were obtained at weekly intervals so that for most babies studied data are available at different postnatal ages and nutrient intakes. For each amino acid profile 0-3 ml of blood was sampled.
Amino acid analysis was carried out on a Hilger Chromaspeck automated ion exchange amino acid analyser. The biochemistry department participates in the external quality control system (NEQUAS) operated by the Wolfson Research Laboratory, Queen Elizabeth Medical Centre, Birmingham. Statistical analysis was performed using Oxstat (Medstat Ltd).
Results
The table shows the 10th, 50th, and 90th centiles for the plasma concentrations of each amino acid.
To see how plasma amino acid concentrations correlated with gestational age, body weight, and postnatal age, four amino acids were selected- The only significant associations were between the plasma concentration of serine, glutamine, cystine, valine, methionine, isoleucine, leucine, and phenylalanine and the total amino acid intake, such that the concentrations were slightly higher at a dose of 3 g/kg/day than at 1 g/kg/day, and between phenylalanine concentrations and postnatal age, such that the mean concentration rose from 100 [tmoWl at 2 days to 187 iimol/I at 10 days (Spearman rank correlation, p<0-001). The poor tolerance of tyrosine exhibited by the very low birthweight infants in this study has implications for the usefulness of the ratio of the plasma concentrations of branched chain amino acids (leucine, isoleucine, and valine) to those of the aromatic amino acids (phenylalanine and tyrosine) as an index of hepatocellular function in this age group. This test is proving to be useful4 15, and the mechanism is as follows: when hepatocytes begin to lose their ability to generate glucose from glycogen for the use of peripheral tissues, the branched chain amino acids are taken up from the plasma as a substitute energy source. At the same time, the failing hepatocytes are less able to metabolise aromatic amino acids, and so the ratio of branched chain to aromatic amino acids in the plasma decreases. Evidence for the clinical usefulness of this ratio is derived mainly from adult studies, but it has been suggested that it may be relevant in the newborn. 16 We would urge caution in the interpretation of this ratio in the parenterally fed preterm baby because of the high frequency of increased tyrosine concentrations. In 92% of our observations the ratio was less than 2, which is the value said to be characteristic of liver failure in the adult. The increases in plasma tyrosine which we have documented almost certainly result from isolated hepatic enzyme immaturity rather than generalised hepatocellular immaturity, as evidenced by the absence of a significant correlation between plasma concentrations of tyrosine and phenylalanine (fig 3) .
The data presented in table 1 provide reference ranges for plasma amino acids in the group that we have described when they were fed Vamin 9 glucose continuously throughout each 24 hours. It can be used as a basis for comparison with other groups and with other nutritional regimens. The absence of any overall correlation between plasma amino acid concentrations and any of the variables that we might have expected to influence them is presumably the result of homoeostatic mechanisms. It has the benefit of allowing the production of reference ranges free of qualifications. 
